Mullti Units France - Amundi MSCI Europe II UCITS ETF (EPA:MEU)
France
· Delayed Price · Currency is EUR | Assets | 700.50M |
| Expense Ratio | 0.25% |
| PE Ratio | 16.76 |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Ex-Dividend Date | n/a |
| Payout Frequency | n/a |
| Payout Ratio | n/a |
| 1-Year Return | +9.53% |
| Volume | 1,810 |
| Open | 198.27 |
| Previous Close | 198.62 |
| Day's Range | 198.27 - 199.08 |
| 52-Week Low | 171.00 |
| 52-Week High | 207.03 |
| Beta | 1.00 |
| Holdings | 404 |
| Inception Date | Jan 10, 2006 |
About MEU
Mullti Units France - Amundi MSCI Europe II UCITS ETF is an exchange traded fund launched and managed by Amundi Asset Management SAS. It invests in the public equity markets of developed countries in Europe. The fund uses derivatives such as swap agreements to invest in the stocks of companies operating across diversified sectors. It invests in the stocks of large-cap and mid-cap companies. The fund seeks to replicate the performance of the MSCI Europe Net Return EUR Index, by employing synthetic replication methodology. Mullti Units France - Amundi MSCI Europe II UCITS ETF was formed on December 13, 2005 and is domiciled in France.
Performance
MEU had a total return of 9.53% in the past year, including dividends. Since the fund's inception, the average annual return has been 4.04%.
Top 10 Holdings
19.66% of assets| Name | Symbol | Weight |
|---|---|---|
| SAP SE | SAP | 2.58% |
| Nestlé S.A. | NESN | 2.36% |
| ASML Holding N.V. | ASML | 2.25% |
| Roche Holding AG | ROG | 1.96% |
| Novartis AG | NOVN | 1.93% |
| AstraZeneca PLC | AZN | 1.87% |
| Novo Nordisk A/S | NOVO.B | 1.77% |
| HSBC Holdings plc | HSBA | 1.74% |
| Shell plc | SHEL | 1.70% |
| Siemens Aktiengesellschaft | SIE | 1.50% |